Biotechnology
The Biotechnology industry has a total of 600 stocks, with a combined market cap of $1.11 trillion and total revenue of $105.3 billion.
Market Cap
1.11T
Revenue
105.3B
Profits
-41.34B
PE Ratio
n/a
Profit Margin
-39.26%
Dividend Yield
0.04%
600 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 111.69B | -0.26% | 605,036 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 75.51B | 0.40% | 316,339 | 14.25B |
| 3 | ARGX | argenx SE | 49.24B | 0.50% | 317,278 | 3.68B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 46.47B | -2.09% | 775,890 | 3.21B |
| 5 | ONC | BeOne Medicines AG | 37.09B | -0.89% | 141,679 | 4.97B |
| 6 | INSM | Insmed Incorporated | 34.69B | 0.77% | 1,154,432 | 447.02M |
| 7 | BNTX | BioNTech SE | 26.86B | -1.78% | 369,330 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 22.71B | -0.53% | 1,002,414 | 2.35B |
| 9 | RVMD | Revolution Medicines, Inc. | 22.43B | -3.55% | 3,792,307 | - |
| 10 | INCY | Incyte Corporation | 20.14B | -3.42% | 1,180,826 | 4.81B |
| 11 | GMAB | Genmab A/S | 19.33B | -2.39% | 1,800,504 | 3.85B |
| 12 | MRNA | Moderna, Inc. | 16.51B | 1.00% | 6,805,106 | 2.23B |
| 13 | ROIV | Roivant Sciences Ltd. | 15.78B | -1.90% | 2,426,684 | 20.33M |
| 14 | BBIO | BridgeBio Pharma, Inc. | 14.73B | 0.25% | 1,182,349 | 353.78M |
| 15 | ASND | Ascendis Pharma A/S | 13.07B | 3.48% | 383,191 | 758.59M |
| 16 | SMMT | Summit Therapeutics Inc. | 12.49B | -4.93% | 1,257,073 | - |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.43B | 0.52% | 2,905,556 | 966.96M |
| 18 | EXEL | Exelixis, Inc. | 11.80B | -0.27% | 781,177 | 2.29B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.49B | 0.81% | 116,375 | 740.64M |
| 20 | RNA | Avidity Biosciences, Inc. | 10.92B | -0.05% | 412,297 | 20.87M |
| 21 | TECH | Bio-Techne Corporation | 10.84B | 1.28% | 1,207,626 | 1.22B |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 10.77B | 2.69% | 1,674,789 | 3.09B |
| 23 | JAZZ | Jazz Pharmaceuticals plc | 10.10B | -1.85% | 272,255 | 4.16B |
| 24 | AXSM | Axsome Therapeutics, Inc. | 9.32B | 4.34% | 612,424 | 561.26M |
| 25 | ABVX | ABIVAX Société Anonyme | 9.15B | 0.26% | 1,645,370 | 6.23M |
| 26 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.92B | 1.63% | 725,005 | 829.45M |
| 27 | PRAX | Praxis Precision Medicines, Inc. | 8.88B | 0.86% | 245,056 | 7.46M |
| 28 | HALO | Halozyme Therapeutics, Inc. | 8.29B | -1.05% | 463,081 | 1.24B |
| 29 | NUVL | Nuvalent, Inc. | 8.26B | 1.97% | 243,100 | - |
| 30 | KRYS | Krystal Biotech, Inc. | 7.98B | -3.47% | 218,977 | 373.16M |
| 31 | CYTK | Cytokinetics, Incorporated | 7.66B | 0.11% | 657,574 | 87.21M |
| 32 | CAI | Caris Life Sciences, Inc. | 7.46B | -1.27% | 854,262 | 649.06M |
| 33 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.77B | -0.20% | 462,476 | 174.33M |
| 34 | IBRX | ImmunityBio, Inc. | 6.48B | 19.20% | 176,082,729 | 82.56M |
| 35 | GPCR | Structure Therapeutics Inc. | 6.26B | 2.15% | 1,261,382 | - |
| 36 | PCVX | Vaxcyte, Inc. | 6.18B | 1.40% | 428,272 | - |
| 37 | COGT | Cogent Biosciences, Inc. | 6.04B | 2.03% | 924,305 | - |
| 38 | BLTE | Belite Bio, Inc | 5.99B | 2.89% | 67,729 | - |
| 39 | PTCT | PTC Therapeutics, Inc. | 5.76B | -1.06% | 439,671 | 1.78B |
| 40 | CRNX | Crinetics Pharmaceuticals, Inc. | 5.62B | -2.11% | 440,784 | 1.54M |
| 41 | APGE | Apogee Therapeutics, Inc. | 5.55B | 1.73% | 198,284 | - |
| 42 | KYMR | Kymera Therapeutics, Inc. | 5.44B | -2.30% | 633,368 | 43.74M |
| 43 | IMVT | Immunovant, Inc. | 5.30B | -0.49% | 321,529 | - |
| 44 | PTGX | Protagonist Therapeutics, Inc. | 5.15B | 0.47% | 244,320 | 209.22M |
| 45 | CRSP | CRISPR Therapeutics AG | 5.07B | -0.56% | 1,076,586 | 38.34M |
| 46 | CELC | Celcuity Inc. | 4.99B | 0.90% | 238,202 | - |
| 47 | MIRM | Mirum Pharmaceuticals, Inc. | 4.73B | 0.56% | 361,830 | 471.79M |
| 48 | SRRK | Scholar Rock Holding Corporation | 4.51B | -1.78% | 456,016 | - |
| 49 | TGTX | TG Therapeutics, Inc. | 4.47B | 0.07% | 1,115,265 | 531.90M |
| 50 | ACAD | ACADIA Pharmaceuticals Inc. | 4.43B | 0.81% | 521,096 | 1.05B |
| 51 | FOLD | Amicus Therapeutics, Inc. | 4.43B | -0.14% | 2,475,528 | 598.70M |
| 52 | CGON | CG Oncology, Inc. | 4.36B | -1.22% | 439,332 | 2.17M |
| 53 | LEGN | Legend Biotech Corporation | 4.34B | 6.14% | 2,362,701 | 909.05M |
| 54 | ACLX | Arcellx, Inc. | 4.19B | 5.16% | 1,752,437 | 35.90M |
| 55 | ADMA | ADMA Biologics, Inc. | 4.12B | 0.12% | 725,422 | 488.56M |
| 56 | TERN | Terns Pharmaceuticals, Inc. | 4.02B | 0.90% | 670,471 | - |
| 57 | LGND | Ligand Pharmaceuticals Incorporated | 3.81B | 0.19% | 76,479 | 251.23M |
| 58 | VKTX | Viking Therapeutics, Inc. | 3.80B | -0.97% | 1,248,083 | - |
| 59 | CORT | Corcept Therapeutics Incorporated | 3.65B | 0.03% | 629,833 | 741.17M |
| 60 | NAMS | NewAmsterdam Pharma Company N.V. | 3.60B | 0.39% | 292,194 | 35.24M |
| 61 | LQDA | Liquidia Corporation | 3.46B | 4.77% | 1,323,556 | 69.22M |
| 62 | CNTA | Centessa Pharmaceuticals plc | 3.31B | 1.94% | 233,270 | 15.00M |
| 63 | XENE | Xenon Pharmaceuticals Inc. | 3.21B | 3.98% | 359,990 | 7.50M |
| 64 | VERA | Vera Therapeutics, Inc. | 3.20B | -3.18% | 620,686 | - |
| 65 | ARQT | Arcutis Biotherapeutics, Inc. | 3.16B | -0.23% | 396,649 | 317.93M |
| 66 | ALMS | Alumis Inc. | 3.14B | 5.66% | 1,464,424 | 22.12M |
| 67 | IDYA | IDEAYA Biosciences, Inc. | 3.14B | -0.20% | 229,046 | 214.83M |
| 68 | VRDN | Viridian Therapeutics, Inc. | 3.11B | -1.92% | 435,989 | 70.79M |
| 69 | BEAM | Beam Therapeutics Inc. | 3.09B | 0.29% | 751,956 | 55.70M |
| 70 | TARS | Tarsus Pharmaceuticals, Inc. | 3.00B | -0.53% | 328,116 | 366.10M |
| 71 | EWTX | Edgewise Therapeutics, Inc. | 2.97B | 2.37% | 640,300 | - |
| 72 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.86B | 2.47% | 761,517 | 578.20M |
| 73 | DNLI | Denali Therapeutics Inc. | 2.77B | -1.39% | 610,752 | - |
| 74 | IRON | Disc Medicine, Inc. | 2.74B | 2.38% | 196,658 | - |
| 75 | DYN | Dyne Therapeutics, Inc. | 2.73B | -0.81% | 1,159,857 | - |
| 76 | ADPT | Adaptive Biotechnologies Corporation | 2.73B | 1.97% | 658,783 | 252.75M |
| 77 | ERAS | Erasca, Inc. | 2.71B | -0.73% | 4,652,241 | - |
| 78 | RCUS | Arcus Biosciences, Inc. | 2.67B | -1.10% | 311,397 | 240.00M |
| 79 | IMNM | Immunome, Inc. | 2.63B | 6.20% | 1,299,677 | 9.68M |
| 80 | TLX | Telix Pharmaceuticals Limited | 2.61B | -1.03% | 84,043 | 664.23M |
| 81 | SYRE | Spyre Therapeutics, Inc. | 2.59B | 0.39% | 239,203 | - |
| 82 | APLS | Apellis Pharmaceuticals, Inc. | 2.55B | 0.90% | 1,235,067 | 1.02B |
| 83 | MLYS | Mineralys Therapeutics, Inc. | 2.51B | -2.96% | 404,145 | - |
| 84 | TVTX | Travere Therapeutics, Inc. | 2.49B | 0.04% | 574,382 | 435.83M |
| 85 | WVE | Wave Life Sciences Ltd. | 2.49B | -0.51% | 1,774,537 | 109.23M |
| 86 | OCUL | Ocular Therapeutix, Inc. | 2.42B | 0.93% | 2,122,505 | 55.78M |
| 87 | AAPG | Ascentage Pharma Group International | 2.40B | -0.36% | 2,810 | 54.52M |
| 88 | RXRX | Recursion Pharmaceuticals, Inc. | 2.35B | -3.43% | 14,618,611 | 43.69M |
| 89 | SLNO | Soleno Therapeutics, Inc. | 2.34B | 2.51% | 754,964 | 98.68M |
| 90 | MESO | Mesoblast Limited | 2.20B | -3.41% | 243,684 | 17.20M |
| 91 | SRPT | Sarepta Therapeutics, Inc. | 2.18B | -1.33% | 746,466 | 2.41B |
| 92 | RARE | Ultragenyx Pharmaceutical Inc. | 2.18B | 0.58% | 896,060 | 630.60M |
| 93 | GLPG | Galapagos NV | 2.10B | -0.45% | 153,750 | 336.64M |
| 94 | ZLAB | Zai Lab Limited | 2.10B | 1.53% | 267,055 | 441.63M |
| 95 | OLMA | Olema Pharmaceuticals, Inc. | 2.09B | -1.95% | 357,002 | - |
| 96 | HRMY | Harmony Biosciences Holdings, Inc. | 2.07B | -0.66% | 343,120 | 825.94M |
| 97 | MAZE | Maze Therapeutics, Inc. | 2.06B | 4.81% | 316,657 | 2.50M |
| 98 | NUVB | Nuvation Bio Inc. | 2.04B | 1.88% | 3,604,318 | 26.75M |
| 99 | DNTH | Dianthus Therapeutics, Inc. | 1.96B | 3.54% | 482,932 | 3.08M |
| 100 | AUPH | Aurinia Pharmaceuticals Inc. | 1.95B | -0.40% | 520,587 | 265.81M |
| 101 | MBX | MBX Biosciences, Inc. | 1.94B | 6.51% | 370,707 | - |
| 102 | GLUE | Monte Rosa Therapeutics, Inc. | 1.91B | 1.81% | 574,862 | 181.54M |
| 103 | NRIX | Nurix Therapeutics, Inc. | 1.89B | -2.76% | 869,190 | 83.69M |
| 104 | ARDX | Ardelyx, Inc. | 1.88B | 14.37% | 10,290,757 | 398.23M |
| 105 | VCEL | Vericel Corporation | 1.84B | -2.83% | 144,284 | 258.72M |
| 106 | SION | Sionna Therapeutics, Inc. | 1.82B | 4.19% | 68,502 | - |
| 107 | ZYME | Zymeworks Inc. | 1.79B | 1.79% | 306,177 | 134.48M |
| 108 | TNGX | Tango Therapeutics, Inc. | 1.76B | 0.58% | 1,620,446 | 66.50M |
| 109 | SNDX | Syndax Pharmaceuticals, Inc. | 1.76B | -1.56% | 500,569 | 111.30M |
| 110 | IMCR | Immunocore Holdings plc | 1.70B | 0.93% | 179,519 | 379.59M |
| 111 | PHVS | Pharvaris N.V. | 1.70B | 4.03% | 57,188 | - |
| 112 | BHVN | Biohaven Ltd. | 1.69B | -2.97% | 1,455,045 | - |
| 113 | CLDX | Celldex Therapeutics, Inc. | 1.69B | -1.13% | 190,088 | 2.60M |
| 114 | UPB | Upstream Bio, Inc. | 1.68B | 0.13% | 483,870 | 2.80M |
| 115 | MNKD | MannKind Corporation | 1.67B | 4.61% | 3,148,310 | 313.79M |
| 116 | KOD | Kodiak Sciences Inc. | 1.64B | -2.43% | 295,300 | - |
| 117 | TYRA | Tyra Biosciences, Inc. | 1.63B | 6.24% | 775,905 | - |
| 118 | ORKA | Oruka Therapeutics, Inc. | 1.62B | 0.27% | 283,237 | - |
| 119 | STOK | Stoke Therapeutics, Inc. | 1.61B | -1.53% | 526,374 | 205.63M |
| 120 | PGEN | Precigen, Inc. | 1.60B | 2.38% | 1,529,879 | 6.31M |
| 121 | RAPT | RAPT Therapeutics, Inc. | 1.59B | 63.83% | 28,220,414 | - |
| 122 | ELVN | Enliven Therapeutics, Inc. | 1.59B | 0.34% | 479,405 | - |
| 123 | AGIO | Agios Pharmaceuticals, Inc. | 1.57B | -0.88% | 468,659 | 44.79M |
| 124 | NTLA | Intellia Therapeutics, Inc. | 1.50B | 3.68% | 5,214,034 | 57.53M |
| 125 | OCS | Oculis Holding AG | 1.50B | 2.78% | 336,153 | 992.00K |
| 126 | INVA | Innoviva, Inc. | 1.46B | 0.57% | 166,651 | 388.52M |
| 127 | FTRE | Fortrea Holdings Inc. | 1.44B | -5.27% | 609,797 | 2.76B |
| 128 | SVRA | Savara Inc. | 1.42B | 1.37% | 521,093 | - |
| 129 | CRVS | Corvus Pharmaceuticals, Inc. | 1.41B | 134.29% | 61,207,485 | - |
| 130 | NVAX | Novavax, Inc. | 1.41B | 8.05% | 8,154,444 | 1.06B |
| 131 | ATAI | AtaiBeckley Inc. | 1.40B | 5.63% | 3,754,459 | 3.02M |
| 132 | QURE | uniQure N.V. | 1.38B | -2.87% | 653,541 | 15.75M |
| 133 | IMTX | Immatics N.V. | 1.36B | 2.95% | 121,494 | 99.45M |
| 134 | TRVI | Trevi Therapeutics, Inc. | 1.31B | -2.48% | 710,443 | - |
| 135 | RLAY | Relay Therapeutics, Inc. | 1.30B | 1.90% | 1,759,987 | 8.36M |
| 136 | DBVT | DBV Technologies S.A. | 1.29B | 0.29% | 492,874 | 5.50M |
| 137 | ANAB | AnaptysBio, Inc. | 1.29B | 1.99% | 175,833 | 169.47M |
| 138 | EYPT | EyePoint, Inc. | 1.29B | 3.28% | 382,551 | 42.34M |
| 139 | XERS | Xeris Biopharma Holdings, Inc. | 1.27B | 1.46% | 923,551 | 266.14M |
| 140 | TSHA | Taysha Gene Therapies, Inc. | 1.26B | 0.88% | 1,615,190 | 6.31M |
| 141 | ABCL | AbCellera Biologics Inc. | 1.25B | 1.21% | 2,663,659 | 35.33M |
| 142 | SEPN | Septerna, Inc. | 1.25B | 6.83% | 88,507 | 22.05M |
| 143 | RAPP | Rapport Therapeutics, Inc. | 1.24B | -2.61% | 110,492 | - |
| 144 | CAPR | Capricor Therapeutics, Inc. | 1.24B | -1.27% | 1,221,513 | 11.13M |
| 145 | SANA | Sana Biotechnology, Inc. | 1.24B | 1.31% | 1,816,795 | - |
| 146 | PHAR | Pharming Group N.V. | 1.21B | -4.88% | 21,765 | 362.27M |
| 147 | IVA | Inventiva S.A. | 1.18B | -3.76% | 440,365 | 19.93M |
| 148 | MLTX | MoonLake Immunotherapeutics | 1.18B | -1.73% | 1,144,795 | - |
| 149 | DAWN | Day One Biopharmaceuticals, Inc. | 1.17B | 11.81% | 3,867,392 | 133.67M |
| 150 | ORIC | ORIC Pharmaceuticals, Inc. | 1.17B | -1.24% | 664,677 | - |
| 151 | PVLA | Palvella Therapeutics, Inc. | 1.16B | -1.63% | 65,656 | - |
| 152 | PHAT | Phathom Pharmaceuticals, Inc. | 1.12B | 1.99% | 400,353 | 147.19M |
| 153 | ZBIO | Zenas BioPharma, Inc. | 1.08B | 0.15% | 426,376 | 15.00M |
| 154 | INBX | Inhibrx Biosciences, Inc. | 1.08B | 3.00% | 59,049 | 1.40M |
| 155 | SPRY | ARS Pharmaceuticals, Inc. | 1.04B | -1.32% | 494,726 | 142.77M |
| 156 | TBPH | Theravance Biopharma, Inc. | 1.03B | 1.60% | 109,276 | 80.33M |
| 157 | CMPX | Compass Therapeutics, Inc. | 1.03B | 1.23% | 522,132 | 850.00K |
| 158 | AKTS | Aktis Oncology, Inc. | 1.02B | -1.37% | 89,880 | 5.56M |
| 159 | NBTX | Nanobiotix S.A. | 1.01B | -1.33% | 5,487 | 11.93M |
| 160 | IOVA | Iovance Biotherapeutics, Inc. | 1.00B | 6.78% | 9,202,979 | 250.43M |
| 161 | VTYX | Ventyx Biosciences, Inc. | 993.74M | -0.29% | 1,404,571 | - |
| 162 | GHRS | GH Research PLC | 981.93M | -6.83% | 290,885 | - |
| 163 | MRVI | Maravai LifeSciences Holdings, Inc. | 975.52M | -2.68% | 481,231 | 192.44M |
| 164 | CTMX | CytomX Therapeutics, Inc. | 926.81M | 1.48% | 2,740,943 | 113.63M |
| 165 | AVBP | ArriVent BioPharma, Inc. | 920.99M | 6.95% | 251,736 | - |
| 166 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 916.67M | 0.39% | 146,428 | - |
| 167 | ANNX | Annexon, Inc. | 915.20M | 1.15% | 1,011,990 | - |
| 168 | BCAX | Bicara Therapeutics Inc. | 914.31M | -0.36% | 301,319 | - |
| 169 | XNCR | Xencor, Inc. | 909.06M | -0.47% | 295,440 | 150.13M |
| 170 | URGN | UroGen Pharma Ltd. | 889.84M | 1.12% | 246,488 | 96.52M |
| 171 | OMER | Omeros Corporation | 864.99M | 1.58% | 1,258,565 | - |
| 172 | DRUG | Bright Minds Biosciences Inc. | 859.74M | -5.22% | 155,498 | - |
| 173 | NBY | NovaBay Pharmaceuticals, Inc. | 854.35M | -54.10% | 2,695,448 | 10.30M |
| 174 | VALN | Valneva SE | 851.63M | -1.69% | 5,363 | 211.09M |
| 175 | VIR | Vir Biotechnology, Inc. | 850.05M | 0.83% | 703,266 | 16.86M |
| 176 | GERN | Geron Corporation | 842.63M | 0.76% | 8,322,825 | 183.40M |
| 177 | ABUS | Arbutus Biopharma Corporation | 813.53M | 4.19% | 1,812,966 | 14.61M |
| 178 | YDES | YD Bio Limited | 808.68M | 1.59% | 43,682 | 510.36K |
| 179 | JANX | Janux Therapeutics, Inc. | 801.17M | -3.20% | 951,037 | 10.00M |
| 180 | ARVN | Arvinas, Inc. | 782.89M | -0.08% | 221,768 | 312.30M |
| 181 | MDXG | MiMedx Group, Inc. | 781.98M | -2.58% | 739,894 | 393.44M |
| 182 | KALV | KalVista Pharmaceuticals, Inc. | 765.27M | 3.70% | 693,073 | 1.43M |
| 183 | KURA | Kura Oncology, Inc. | 753.57M | 2.36% | 1,092,926 | 104.03M |
| 184 | MPLT | MapLight Therapeutics, Inc. | 729.25M | -1.71% | 40,097 | - |
| 185 | NKTR | Nektar Therapeutics | 726.40M | -5.23% | 354,600 | 62.60M |
| 186 | FULC | Fulcrum Therapeutics, Inc. | 716.44M | 7.10% | 1,011,784 | 80.00M |
| 187 | ATXS | Astria Therapeutics, Inc. | 710.14M | -0.24% | 263,331 | 706.00K |
| 188 | GYRE | Gyre Therapeutics, Inc. | 708.04M | 1.43% | 37,358 | 107.27M |
| 189 | RGNX | REGENXBIO Inc. | 705.69M | 2.35% | 540,222 | 161.32M |
| 190 | SLS | SELLAS Life Sciences Group, Inc. | 704.97M | 4.02% | 6,034,559 | - |
| 191 | PRME | Prime Medicine, Inc. | 703.73M | -0.13% | 1,680,113 | 5.98M |
| 192 | JBIO | Jade Biosciences, Inc. | 702.94M | 3.95% | 119,902 | - |
| 193 | VOR | Vor Biopharma Inc. | 701.22M | 14.98% | 1,787,758 | - |
| 194 | IVVD | Invivyd, Inc. | 658.44M | -4.69% | 1,833,655 | 50.04M |
| 195 | RIGL | Rigel Pharmaceuticals, Inc. | 658.35M | -3.23% | 183,628 | 282.08M |
| 196 | PROK | ProKidney Corp. | 654.31M | -5.02% | 870,974 | 744.00K |
| 197 | TENX | Tenax Therapeutics, Inc. | 649.13M | -0.31% | 117,390 | - |
| 198 | CGEM | Cullinan Therapeutics, Inc. | 638.61M | 0.84% | 298,481 | - |
| 199 | LENZ | LENZ Therapeutics, Inc. | 609.53M | 6.51% | 645,165 | 17.50M |
| 200 | ENGN | enGene Holdings Inc. | 602.86M | -3.33% | 398,212 | - |
| 201 | MGTX | MeiraGTx Holdings plc | 599.66M | 0.40% | 182,773 | 27.42M |
| 202 | GOSS | Gossamer Bio, Inc. | 599.47M | 2.78% | 2,477,427 | 44.05M |
| 203 | EVMN | Evommune, Inc. | 579.73M | 9.46% | 111,860 | 13.00M |
| 204 | KROS | Keros Therapeutics, Inc. | 567.28M | -1.27% | 93,452 | 246.72M |
| 205 | FBRX | Forte Biosciences, Inc. | 561.60M | -5.68% | 131,331 | - |
| 206 | DRTS | Alpha Tau Medical Ltd. | 558.48M | -8.01% | 546,961 | - |
| 207 | LBRX | LB Pharmaceuticals Inc | 553.92M | 9.64% | 120,828 | - |
| 208 | ANRO | Alto Neuroscience, Inc. | 553.14M | 3.70% | 110,845 | - |
| 209 | REPL | Replimune Group, Inc. | 550.67M | -0.28% | 1,025,477 | - |
| 210 | DSGN | Design Therapeutics, Inc. | 535.46M | 1.29% | 145,700 | - |
| 211 | LXEO | Lexeo Therapeutics, Inc. | 534.27M | -0.95% | 829,459 | - |
| 212 | CRMD | CorMedix Inc. | 534.19M | - | 1,441,446 | 214.30M |
| 213 | VSTM | Verastem, Inc. | 518.66M | 0.60% | 911,451 | 13.38M |
| 214 | OCGN | Ocugen, Inc. | 516.89M | -2.07% | 3,343,961 | 5.37M |
| 215 | KYTX | Kyverna Therapeutics, Inc. | 515.31M | 7.89% | 617,612 | - |
| 216 | DNA | Ginkgo Bioworks Holdings, Inc. | 512.09M | -5.65% | 642,334 | 180.61M |
| 217 | PRTA | Prothena Corporation plc | 509.23M | 1.18% | 303,153 | 11.79M |
| 218 | LYEL | Lyell Immunopharma, Inc. | 508.37M | 0.72% | 64,016 | 41.00K |
| 219 | NAGE | Niagen Bioscience, Inc. | 498.55M | 0.57% | 378,312 | 124.71M |
| 220 | ZVRA | Zevra Therapeutics, Inc. | 492.32M | -2.07% | 274,417 | 84.39M |
| 221 | LXRX | Lexicon Pharmaceuticals, Inc. | 481.50M | -3.28% | 1,282,434 | 70.86M |
| 222 | MNPR | Monopar Therapeutics Inc. | 468.65M | 0.19% | 195,318 | - |
| 223 | BCYC | Bicycle Therapeutics plc | 460.60M | 2.00% | 142,457 | 28.34M |
| 224 | ALT | Altimmune, Inc. | 459.00M | -0.83% | 1,447,802 | 20.00K |
| 225 | ACRS | Aclaris Therapeutics, Inc. | 450.72M | 58.78% | 11,732,360 | 15.74M |
| 226 | NBP | NovaBridge Biosciences | 449.64M | 4.56% | 956,322 | - |
| 227 | AVXL | Anavex Life Sciences Corp. | 449.42M | 0.40% | 969,334 | - |
| 228 | ASMB | Assembly Biosciences, Inc. | 446.36M | -3.92% | 117,155 | 37.19M |
| 229 | VNDA | Vanda Pharmaceuticals Inc. | 445.00M | 0.80% | 409,937 | 212.07M |
| 230 | ABSI | Absci Corporation | 440.59M | -2.98% | 2,910,526 | 2.82M |
| 231 | ADCT | ADC Therapeutics SA | 439.14M | -2.07% | 204,279 | 75.21M |
| 232 | EPRX | Eupraxia Pharmaceuticals Inc. | 438.09M | 1.60% | 86,744 | - |
| 233 | PRTC | PureTech Health plc | 435.60M | -4.91% | 3,414 | 6.39M |
| 234 | SLDB | Solid Biosciences Inc. | 434.35M | 1.92% | 308,164 | - |
| 235 | FDMT | 4D Molecular Therapeutics, Inc. | 432.23M | 0.20% | 372,855 | 120.00K |
| 236 | VTVT | vTv Therapeutics Inc. | 415.70M | -5.87% | 13,616 | 17.00K |
| 237 | IMMP | Immutep Limited | 415.52M | -2.38% | 62,287 | 3.31M |
| 238 | CTNM | Contineum Therapeutics, Inc. | 411.87M | -3.96% | 82,729 | - |
| 239 | PEPG | PepGen Inc. | 408.36M | 14.23% | 1,019,637 | - |
| 240 | LCTX | Lineage Cell Therapeutics, Inc. | 403.48M | -2.06% | 544,590 | 10.82M |
| 241 | BNTC | Benitec Biopharma Inc. | 399.91M | 1.11% | 27,518 | - |
| 242 | DMAC | DiaMedica Therapeutics Inc. | 396.48M | -2.31% | 365,446 | - |
| 243 | RCKT | Rocket Pharmaceuticals, Inc. | 389.60M | -1.10% | 1,260,868 | - |
| 244 | AUTL | Autolus Therapeutics plc | 387.24M | 5.43% | 1,172,831 | 51.13M |
| 245 | TRDA | Entrada Therapeutics, Inc. | 386.23M | -2.09% | 135,890 | 61.52M |
| 246 | HELP | Cybin Inc. | 381.76M | -1.16% | 222,944 | - |
| 247 | ENTA | Enanta Pharmaceuticals, Inc. | 361.94M | -0.56% | 78,619 | 65.32M |
| 248 | TECX | Tectonic Therapeutic, Inc. | 358.14M | 1.78% | 108,075 | - |
| 249 | ALLO | Allogene Therapeutics, Inc. | 357.32M | -2.45% | 2,782,373 | 22.00K |
| 250 | ACIU | AC Immune SA | 343.33M | -1.14% | 214,298 | 5.48M |
| 251 | CADL | Candel Therapeutics, Inc. | 343.11M | -2.34% | 655,165 | - |
| 252 | FHTX | Foghorn Therapeutics Inc. | 339.19M | -3.82% | 113,328 | 24.52M |
| 253 | AARD | Aardvark Therapeutics, Inc. | 334.00M | -0.20% | 225,419 | - |
| 254 | XOMA | XOMA Royalty Corporation | 331.62M | 1.55% | 624,074 | 47.11M |
| 255 | ZURA | Zura Bio Limited | 331.62M | 6.03% | 426,162 | - |
| 256 | PBYI | Puma Biotechnology, Inc. | 329.31M | 2.59% | 361,847 | 212.00M |
| 257 | NMRA | Neumora Therapeutics, Inc. | 325.43M | -5.20% | 530,253 | - |
| 258 | XFOR | X4 Pharmaceuticals, Inc. | 322.64M | -0.27% | 210,456 | 33.98M |
| 259 | AURA | Aura Biosciences, Inc. | 318.15M | -0.20% | 130,986 | - |
| 260 | IMRX | Immuneering Corporation | 308.00M | 4.15% | 1,139,911 | - |
| 261 | CLLS | Cellectis S.A. | 300.20M | 1.72% | 8,675 | 82.55M |
| 262 | GUTS | Fractyl Health, Inc. | 298.31M | 1.83% | 2,929,065 | 3.00K |
| 263 | TARA | Protara Therapeutics, Inc. | 297.95M | 10.98% | 630,310 | - |
| 264 | ACHV | Achieve Life Sciences, Inc. | 297.58M | -4.12% | 683,450 | - |
| 265 | GLSI | Greenwich LifeSciences, Inc. | 295.24M | -14.35% | 527,534 | - |
| 266 | RLMD | Relmada Therapeutics, Inc. | 293.33M | 6.95% | 575,606 | - |
| 267 | ALDX | Aldeyra Therapeutics, Inc. | 287.88M | 3.35% | 598,689 | - |
| 268 | ABEO | Abeona Therapeutics Inc. | 287.49M | 1.05% | 851,805 | 400.00K |
| 269 | MENS | Jyong Biotech Ltd. | 278.38M | 8.71% | 484,230 | - |
| 270 | AVTX | Avalo Therapeutics, Inc. | 278.06M | -0.27% | 240,250 | 192.00K |
| 271 | OABI | OmniAb, Inc. | 277.83M | 1.58% | 142,316 | 21.09M |
| 272 | CBIO | Crescent Biopharma, Inc. | 274.57M | 3.96% | 147,333 | - |
| 273 | LRMR | Larimar Therapeutics, Inc. | 273.89M | 2.24% | 475,714 | - |
| 274 | STTK | Shattuck Labs, Inc. | 272.74M | -7.11% | 385,445 | 1.00M |
| 275 | NGNE | Neurogene Inc. | 269.68M | -0.80% | 44,135 | 925.00K |
| 276 | HRTX | Heron Therapeutics, Inc. | 268.63M | -1.68% | 757,777 | 155.10M |
| 277 | NAUT | Nautilus Biotechnology, Inc. | 267.77M | 6.00% | 109,103 | - |
| 278 | AVIR | Atea Pharmaceuticals, Inc. | 267.58M | 0.74% | 104,457 | - |
| 279 | RZLT | Rezolute, Inc. | 264.27M | 4.40% | 2,092,987 | - |
| 280 | PALI | Palisade Bio, Inc. | 262.25M | 6.02% | 7,261,079 | - |
| 281 | CAMP | Camp4 Therapeutics Corporation | 256.81M | -11.92% | 48,217 | 3.80M |
| 282 | FENC | Fennec Pharmaceuticals Inc. | 253.08M | -2.37% | 44,250 | 38.79M |
| 283 | IMMX | Immix Biopharma, Inc. | 247.67M | - | 352,047 | - |
| 284 | SLN | Silence Therapeutics plc | 236.17M | -0.79% | 165,970 | 25.83M |
| 285 | ENLV | Enlivex Therapeutics Ltd. | 232.63M | 4.26% | 294,622 | - |
| 286 | OBIO | Orchestra BioMed Holdings, Inc. | 227.84M | -4.38% | 78,722 | 2.82M |
| 287 | IKT | Inhibikase Therapeutics, Inc. | 227.06M | -0.60% | 202,459 | 1.00 |
| 288 | ARMP | Armata Pharmaceuticals, Inc. | 217.53M | -6.64% | 35,471 | 5.05M |
| 289 | MDWD | MediWound Ltd. | 217.20M | 4.25% | 95,003 | 20.93M |
| 290 | CABA | Cabaletta Bio, Inc. | 213.71M | 0.91% | 1,824,763 | - |
| 291 | TNXP | Tonix Pharmaceuticals Holding Corp. | 213.63M | 0.58% | 297,134 | 10.30M |
| 292 | CGEN | Compugen Ltd. | 210.45M | -4.66% | 476,829 | 6.90M |
| 293 | NVCT | Nuvectis Pharma, Inc. | 210.04M | -3.30% | 16,598 | - |
| 294 | CLYM | Climb Bio, Inc. | 209.84M | 4.15% | 320,980 | - |
| 295 | CCCC | C4 Therapeutics, Inc. | 209.82M | -2.91% | 859,450 | 30.11M |
| 296 | TLSA | Tiziana Life Sciences Ltd | 207.87M | -1.19% | 622,778 | - |
| 297 | VYGR | Voyager Therapeutics, Inc. | 207.39M | -0.80% | 450,861 | 31.32M |
| 298 | MIST | Milestone Pharmaceuticals Inc. | 206.21M | -0.98% | 1,192,631 | - |
| 299 | ARCT | Arcturus Therapeutics Holdings Inc. | 204.30M | -1.37% | 304,339 | 97.60M |
| 300 | HUMA | Humacyte, Inc. | 203.61M | -4.95% | 2,817,982 | 1.57M |
| 301 | SGMT | Sagimet Biosciences Inc. | 202.61M | 1.47% | 331,483 | - |
| 302 | OVID | Ovid Therapeutics Inc. | 201.79M | -1.27% | 799,905 | 6.61M |
| 303 | QNCX | Quince Therapeutics, Inc. | 201.01M | 1.69% | 1,049,925 | - |
| 304 | ALEC | Alector, Inc. | 200.84M | - | 452,216 | 69.05M |
| 305 | EDIT | Editas Medicine, Inc. | 199.14M | 0.49% | 1,142,158 | 46.38M |
| 306 | NERV | Minerva Neurosciences, Inc. | 195.60M | 1.57% | 28,220 | - |
| 307 | RNAC | Cartesian Therapeutics, Inc. | 193.47M | 0.27% | 48,898 | 1.09M |
| 308 | SABS | SAB Biotherapeutics, Inc. | 191.86M | 1.26% | 416,070 | 114.70K |
| 309 | GALT | Galectin Therapeutics Inc. | 190.84M | -2.63% | 220,047 | - |
| 310 | CRDF | Cardiff Oncology, Inc. | 190.63M | -1.74% | 309,427 | 501.00K |
| 311 | SLGL | Sol-Gel Technologies Ltd. | 190.27M | -1.73% | 4,555 | 18.97M |
| 312 | ZNTL | Zentalis Pharmaceuticals, Inc. | 187.78M | -2.03% | 569,799 | 26.87M |
| 313 | CHRS | Coherus Oncology, Inc. | 186.14M | -3.75% | 847,328 | 277.73M |
| 314 | IPSC | Century Therapeutics, Inc. | 178.99M | -5.53% | 2,521,141 | 113.34M |
| 315 | KLRS | Kalaris Therapeutics, Inc. | 178.42M | -2.05% | 29,159 | - |
| 316 | PRQR | ProQR Therapeutics N.V. | 176.98M | 1.82% | 170,853 | 18.86M |
| 317 | ELDN | Eledon Pharmaceuticals, Inc. | 176.16M | 4.72% | 540,450 | - |
| 318 | VXRT | Vaxart, Inc. | 168.39M | 7.95% | 1,572,642 | 148.20M |
| 319 | RANI | Rani Therapeutics Holdings, Inc. | 166.48M | -1.44% | 495,397 | 1.20M |
| 320 | SRZN | Surrozen, Inc. | 165.09M | -3.70% | 36,991 | 3.60M |
| 321 | IPHA | Innate Pharma S.A. | 163.64M | 3.27% | 59,422 | 14.84M |
| 322 | PLX | Protalix BioTherapeutics, Inc. | 162.85M | -0.74% | 241,562 | 61.84M |
| 323 | NTHI | NeOnc Technologies Holdings, Inc. | 160.86M | -5.38% | 15,504 | 59.99K |
| 324 | PRLD | Prelude Therapeutics Incorporated | 158.20M | 6.08% | 195,162 | 10.50M |
| 325 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 158.05M | 2.52% | 53,902 | - |
| 326 | TNYA | Tenaya Therapeutics, Inc. | 152.36M | -3.54% | 2,896,126 | - |
| 327 | CDXS | Codexis, Inc. | 148.13M | -1.80% | 210,562 | 52.93M |
| 328 | IRD | Opus Genetics, Inc. | 146.89M | 1.43% | 206,549 | 14.63M |
| 329 | MOLN | Molecular Partners AG | 145.01M | -2.14% | 7,616 | 856.30K |
| 330 | NKTX | Nkarta, Inc. | 144.90M | - | 231,550 | - |
| 331 | UNCY | Unicycive Therapeutics, Inc. | 140.77M | 5.82% | 635,137 | - |
| 332 | TTRX | Turn Therapeutics Inc. | 138.98M | 3.51% | 44,163 | - |
| 333 | ELTX | Elicio Therapeutics, Inc. | 138.93M | -3.64% | 47,434 | - |
| 334 | ORMP | Oramed Pharmaceuticals Inc. | 138.51M | -5.43% | 228,652 | 2.00M |
| 335 | BDTX | Black Diamond Therapeutics, Inc. | 137.88M | -5.47% | 986,558 | 70.00M |
| 336 | MCRB | Seres Therapeutics, Inc. | 137.24M | -4.95% | 29,806 | 351.00K |
| 337 | WHWK | Whitehawk Therapeutics, Inc. | 135.73M | -1.03% | 56,011 | 14.38M |
| 338 | CNTB | Connect Biopharma Holdings Limited | 134.17M | 11.11% | 30,813 | 762.00K |
| 339 | SPRO | Spero Therapeutics, Inc. | 133.81M | -1.45% | 206,303 | 40.55M |
| 340 | CRBU | Caribou Biosciences, Inc. | 133.19M | -2.40% | 785,877 | 9.30M |
| 341 | FATE | Fate Therapeutics, Inc. | 130.35M | -5.04% | 1,057,076 | 7.14M |
| 342 | SGMO | Sangamo Therapeutics, Inc. | 129.89M | -3.84% | 5,196,066 | 32.88M |
| 343 | CNTX | Context Therapeutics Inc. | 129.55M | -2.08% | 713,223 | - |
| 344 | ACTU | Actuate Therapeutics, Inc. | 127.72M | -3.43% | 8,866 | - |
| 345 | STRO | Sutro Biopharma, Inc. | 126.13M | 7.13% | 98,396 | 105.65M |
| 346 | ACOG | Alpha Cognition Inc. | 124.15M | -0.17% | 38,153 | 7.43M |
| 347 | CGTX | Cognition Therapeutics, Inc. | 122.70M | -4.79% | 862,040 | - |
| 348 | GNLX | Genelux Corporation | 121.78M | 0.36% | 151,100 | 8.00K |
| 349 | VRCA | Verrica Pharmaceuticals Inc. | 116.09M | - | 99,160 | 30.83M |
| 350 | ABOS | Acumen Pharmaceuticals, Inc. | 114.00M | -0.42% | 56,585 | - |
| 351 | AGEN | Agenus Inc. | 113.93M | 0.30% | 581,158 | 106.83M |
| 352 | MGNX | MacroGenics, Inc. | 113.87M | 4.65% | 618,147 | 127.63M |
| 353 | ARTV | Artiva Biotherapeutics, Inc. | 112.71M | 3.89% | 139,891 | 251.00K |
| 354 | RPTX | Repare Therapeutics Inc. | 111.44M | 0.19% | 3,910,274 | 11.87M |
| 355 | KPTI | Karyopharm Therapeutics Inc. | 110.59M | -4.28% | 266,394 | 142.53M |
| 356 | THAR | Tharimmune, Inc. | 109.17M | - | 462,865 | - |
| 357 | FBIO | Fortress Biotech, Inc. | 107.70M | -6.72% | 589,282 | 62.30M |
| 358 | ONCY | Oncolytics Biotech Inc. | 106.92M | -1.62% | 501,445 | - |
| 359 | PYXS | Pyxis Oncology, Inc. | 106.47M | -2.84% | 430,620 | 2.82M |
| 360 | INO | Inovio Pharmaceuticals, Inc. | 105.80M | 1.32% | 765,230 | 182.34K |
| 361 | SEER | Seer, Inc. | 104.91M | -1.32% | 38,838 | 16.38M |
| 362 | ANIX | Anixa Biosciences, Inc. | 103.80M | -2.51% | 156,797 | - |
| 363 | BMEA | Biomea Fusion, Inc. | 100.40M | 0.71% | 699,292 | - |
| 364 | ETHZ | ETHZilla Corporation | 100.38M | -5.55% | 445,268 | 4.11M |
| 365 | CSBR | Champions Oncology, Inc. | 98.73M | -1.39% | 393 | 58.42M |
| 366 | VANI | Vivani Medical, Inc. | 98.49M | 6.30% | 478,690 | - |
| 367 | DTIL | Precision BioSciences, Inc. | 98.21M | 0.74% | 74,855 | 698.00K |
| 368 | CBUS | Cibus, Inc. | 96.79M | -6.05% | 133,244 | 3.79M |
| 369 | SAVA | Cassava Sciences, Inc. | 96.62M | -1.96% | 521,097 | - |
| 370 | HYFT | MindWalk Holdings Corp. | 93.85M | -2.90% | 256,392 | 19.02M |
| 371 | COYA | Coya Therapeutics, Inc. | 93.64M | 4.56% | 230,147 | 3.99M |
| 372 | MREO | Mereo BioPharma Group plc | 93.28M | -8.41% | 6,950,893 | 500.00K |
| 373 | EXOZ | eXoZymes, Inc. | 91.06M | 3.14% | 4,886 | -700.00 |
| 374 | ADAG | Adagene Inc. | 89.55M | -3.06% | 13,973 | 103.20K |
| 375 | DWTX | Dogwood Therapeutics, Inc. | 88.23M | -1.08% | 15,012 | - |
| 376 | MAIA | MAIA Biotechnology, Inc. | 82.85M | 24.43% | 3,022,992 | - |
| 377 | OKYO | OKYO Pharma Limited | 82.72M | -0.48% | 107,740 | - |
| 378 | MNOV | MediciNova, Inc. | 82.57M | 5.00% | 54,414 | 257.92K |
| 379 | ACET | Adicet Bio, Inc. | 81.66M | -2.42% | 141,540 | - |
| 380 | KRRO | Korro Bio, Inc. | 81.27M | -1.71% | 77,164 | 7.37M |
| 381 | SPRB | Spruce Biosciences, Inc. | 80.01M | 1.66% | 12,061 | 697.00K |
| 382 | IMUX | Immunic, Inc. | 78.68M | 5.84% | 1,237,880 | - |
| 383 | PLRX | Pliant Therapeutics, Inc. | 78.04M | -1.55% | 377,976 | - |
| 384 | XBIT | XBiotech Inc. | 77.74M | -0.78% | 61,718 | - |
| 385 | ATOS | Atossa Therapeutics, Inc. | 77.50M | -2.44% | 3,011,982 | - |
| 386 | CALC | CalciMedica, Inc. | 76.80M | 3.90% | 29,368 | - |
| 387 | GANX | Gain Therapeutics, Inc. | 76.54M | 9.94% | 680,328 | - |
| 388 | KZIA | Kazia Therapeutics Limited | 76.38M | -2.09% | 60,429 | 1.20M |
| 389 | ENTX | Entera Bio Ltd. | 75.66M | 1.85% | 30,662 | 124.00K |
| 390 | ANVS | Annovis Bio, Inc. | 73.68M | -3.81% | 498,010 | - |
| 391 | PYPD | PolyPid Ltd. | 72.69M | - | 59,465 | - |
| 392 | PTHS | Pelthos Therapeutics Inc. | 71.33M | 0.22% | 3,112 | 7.41M |
| 393 | COEP | Coeptis Therapeutics Holdings, Inc. | 71.00M | -1.34% | 49,301 | 501.00K |
| 394 | ALXO | ALX Oncology Holdings Inc. | 70.48M | 11.11% | 209,550 | - |
| 395 | EQ | Equillium, Inc. | 70.33M | 0.43% | 296,951 | 4.39M |
| 396 | ATYR | aTyr Pharma, Inc. | 70.00M | 0.82% | 482,489 | 190.00K |
| 397 | BYSI | BeyondSpring Inc. | 69.91M | -0.58% | 40,176 | 1.88M |
| 398 | ANL | Adlai Nortye Ltd. | 67.16M | 1.11% | 56,872 | -1.35M |
| 399 | IFRX | InflaRx N.V. | 67.00M | -1.11% | 741,113 | 73.73K |
| 400 | IMA | ImageneBio, Inc. | 66.41M | -4.52% | 42,532 | 800.00K |
| 401 | TCRX | TScan Therapeutics, Inc. | 65.26M | 1.77% | 283,881 | 8.42M |
| 402 | TVGN | Tevogen Bio Holdings Inc. | 65.18M | -3.72% | 217,739 | - |
| 403 | NRXP | NRx Pharmaceuticals, Inc. | 65.13M | -3.08% | 762,325 | 242.00K |
| 404 | CRVO | CervoMed Inc. | 64.86M | -3.71% | 68,789 | 6.16M |
| 405 | ACRV | Acrivon Therapeutics, Inc. | 64.53M | 3.28% | 1,705,173 | - |
| 406 | ATHE | Alterity Therapeutics Limited | 62.06M | -4.06% | 5,457 | 3.57M |
| 407 | MGX | Metagenomi Therapeutics, Inc. | 61.58M | -1.20% | 195,942 | 30.91M |
| 408 | ICCC | ImmuCell Corporation | 60.34M | 4.87% | 12,691 | 27.77M |
| 409 | PMVP | PMV Pharmaceuticals, Inc. | 59.61M | -0.86% | 171,409 | - |
| 410 | RADX | Radiopharm Theranostics Limited | 57.10M | -1.11% | 64,394 | 8.20M |
| 411 | INKT | MiNK Therapeutics, Inc. | 56.69M | 0.98% | 8,041 | - |
| 412 | LPCN | Lipocine Inc. | 56.24M | -8.99% | 112,451 | 4.32M |
| 413 | GRCE | Grace Therapeutics, Inc. | 55.71M | -1.37% | 208,379 | - |
| 414 | NTRB | Nutriband Inc. | 53.49M | 0.92% | 12,628 | 2.28M |
| 415 | OSTX | OS Therapies Incorporated | 52.82M | 2.74% | 817,886 | - |
| 416 | PDSB | PDS Biotechnology Corporation | 52.51M | 0.86% | 449,953 | - |
| 417 | IBIO | iBio, Inc. | 51.27M | 3.64% | 883,596 | 500.00K |
| 418 | PSTV | Plus Therapeutics, Inc. | 51.02M | 0.21% | 10,737,387 | 5.26M |
| 419 | ABVC | ABVC BioPharma, Inc. | 50.91M | 6.93% | 37,595 | 797.92K |
| 420 | NRXS | NeurAxis, Inc. | 50.07M | 2.84% | 92,742 | 3.36M |
| 421 | ALGS | Aligos Therapeutics, Inc. | 49.72M | 1.76% | 57,342 | 2.65M |
| 422 | LITS | Lite Strategy, Inc. | 49.27M | -6.29% | 218,714 | - |
| 423 | TIL | Instil Bio, Inc. | 48.08M | 0.28% | 51,842 | - |
| 424 | CVM | CEL-SCI Corporation | 47.93M | 10.68% | 69,156 | - |
| 425 | IBO | Impact BioMedical Inc. | 47.62M | 0.82% | 29,503 | 25.00K |
| 426 | QTTB | Q32 Bio Inc. | 47.37M | 6.94% | 182,726 | - |
| 427 | TELO | Telomir Pharmaceuticals, Inc. | 46.87M | -1.92% | 106,286 | - |
| 428 | APLM | Apollomics, Inc. | 46.25M | 3.86% | 5,145 | 6.93M |
| 429 | NXTC | NextCure, Inc. | 45.91M | 1.43% | 9,396 | - |
| 430 | KZR | Kezar Life Sciences, Inc. | 45.70M | 0.65% | 7,883 | - |
| 431 | TVRD | Tvardi Therapeutics, Inc. | 44.28M | 3.28% | 34,671 | - |
| 432 | JSPR | Jasper Therapeutics, Inc. | 44.21M | 3.27% | 320,255 | - |
| 433 | CING | Cingulate Inc. | 44.11M | 9.45% | 319,199 | - |
| 434 | ANEB | Anebulo Pharmaceuticals, Inc. | 43.96M | -1.83% | 125,566 | - |
| 435 | INMB | INmune Bio, Inc. | 43.33M | -5.78% | 253,218 | 50.00K |
| 436 | HURA | TuHURA Biosciences, Inc. | 42.81M | -7.28% | 116,281 | - |
| 437 | VERU | Veru Inc. | 41.73M | -3.35% | 133,175 | 16.89M |
| 438 | ESLA | Estrella Immunopharma, Inc. | 41.61M | -0.40% | 14,599 | - |
| 439 | XLO | Xilio Therapeutics, Inc. | 41.37M | -4.31% | 176,919 | 31.80M |
| 440 | ATNM | Actinium Pharmaceuticals, Inc. | 40.55M | -2.26% | 102,887 | 90.00K |
| 441 | OKUR | OnKure Therapeutics, Inc. | 39.97M | -1.67% | 30,688 | - |
| 442 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 39.75M | -5.45% | 3,061,379 | - |
| 443 | GLTO | Galecto, Inc. | 39.45M | -1.10% | 17,849 | - |
| 444 | EVAX | Evaxion A/S | 39.28M | 3.52% | 43,000 | 7.65M |
| 445 | LTRN | Lantern Pharma Inc. | 39.26M | 2.63% | 104,016 | - |
| 446 | XCUR | Exicure, Inc. | 39.15M | -1.24% | 30,171 | 500.00K |
| 447 | PASG | Passage Bio, Inc. | 38.88M | -4.97% | 52,550 | - |
| 448 | IOBT | IO Biotech, Inc. | 37.82M | 4.70% | 594,358 | - |
| 449 | GBIO | Generation Bio Co. | 37.79M | -0.36% | 51,496 | 15.27M |
| 450 | CELU | Celularity Inc. | 37.49M | -0.76% | 27,763 | 40.58M |
| 451 | RNXT | RenovoRx, Inc. | 37.36M | -0.05% | 139,636 | 928.00K |
| 452 | KYNB | Kyntra Bio, Inc. | 36.85M | -0.33% | 29,177 | 8.30M |
| 453 | OTLK | Outlook Therapeutics, Inc. | 34.03M | -2.82% | 1,820,635 | 1.41M |
| 454 | ANTX | AN2 Therapeutics, Inc. | 32.75M | -0.42% | 51,230 | - |
| 455 | DYAI | Dyadic International, Inc. | 32.46M | 3.09% | 23,372 | 3.34M |
| 456 | ATRA | Atara Biotherapeutics, Inc. | 31.87M | -2.64% | 385,118 | 151.93M |
| 457 | SKYE | Skye Bioscience, Inc. | 31.77M | -0.91% | 91,640 | - |
| 458 | MRKR | Marker Therapeutics, Inc. | 31.35M | 3.87% | 260,841 | 4.69M |
| 459 | JUNS | Jupiter Neurosciences, Inc. | 31.30M | 5.87% | 36,563 | - |
| 460 | BCTX | BriaCell Therapeutics Corp. | 31.07M | 1.86% | 412,554 | - |
| 461 | RNTX | Rein Therapeutics Inc. | 30.76M | -3.31% | 267,328 | - |
| 462 | SER | Serina Therapeutics, Inc. | 30.61M | -7.42% | 42,050 | 116.00K |
| 463 | BRNS | Barinthus Biotherapeutics plc | 29.61M | - | 37,839 | 14.97M |
| 464 | GNTA | Genenta Science S.p.A. | 29.52M | -3.08% | 37,717 | - |
| 465 | PTN | Palatin Technologies, Inc. | 28.83M | -1.54% | 11,040 | 8.85M |
| 466 | NRSN | NeuroSense Therapeutics Ltd. | 28.32M | 0.33% | 146,720 | - |
| 467 | PLUR | Pluri Inc. | 28.14M | -5.28% | 909 | 1.33M |
| 468 | BOLD | Boundless Bio, Inc. | 28.09M | 1.21% | 533,424 | - |
| 469 | DARE | Daré Bioscience, Inc. | 27.72M | 0.52% | 70,240 | -57.13K |
| 470 | QNTM | Quantum BioPharma Ltd. | 27.54M | 0.57% | 28,445 | - |
| 471 | HOWL | Werewolf Therapeutics, Inc. | 27.52M | 3.22% | 454,600 | 1.14M |
| 472 | IGC | IGC Pharma, Inc. | 27.51M | -3.10% | 361,494 | 1.11M |
| 473 | SNTI | Senti Biosciences, Inc. | 27.34M | 0.97% | 217,114 | - |
| 474 | CUE | Cue Biopharma, Inc. | 26.77M | -2.85% | 412,663 | 7.10M |
| 475 | PBM | Psyence Biomedical Ltd. | 26.75M | -0.02% | 81,091 | - |
| 476 | RLYB | Rallybio Corporation | 26.20M | -5.57% | 284,456 | 674.00K |
| 477 | LIXT | Lixte Biotechnology Holdings, Inc. | 25.96M | -10.24% | 50,186 | - |
| 478 | VTGN | Vistagen Therapeutics, Inc. | 25.68M | -2.03% | 719,903 | 721.00K |
| 479 | HYPD | Hyperion DeFi, Inc. | 25.11M | -8.28% | 327,971 | 345.32K |
| 480 | NNVC | NanoViricides, Inc. | 24.80M | -2.54% | 133,031 | - |
| 481 | INTS | Intensity Therapeutics, Inc. | 24.79M | 1.08% | 1,420,330 | - |
| 482 | PLRZ | Polyrizon Ltd. | 24.29M | -1.99% | 37,930 | - |
| 483 | LONA | LeonaBio, Inc. | 24.06M | - | 42,624 | - |
| 484 | KLTO | Klotho Neurosciences, Inc. | 23.16M | -3.96% | 221,041 | - |
| 485 | FBLG | FibroBiologics, Inc. | 21.98M | -1.31% | 469,014 | - |
| 486 | NEUP | Neuphoria Therapeutics Inc. | 21.51M | -2.68% | 32,187 | 15.65M |
| 487 | KTTA | Pasithea Therapeutics Corp. | 21.02M | -1.67% | 139,263 | - |
| 488 | ALLR | Allarity Therapeutics, Inc. | 21.01M | 2.54% | 72,719 | - |
| 489 | BCAB | BioAtla, Inc. | 20.91M | 2.27% | 1,348,935 | 11.00M |
| 490 | LNAI | Lunai Bioworks Inc. | 20.09M | -7.33% | 103,198 | - |
| 491 | LIMN | Liminatus Pharma, Inc. | 19.74M | -5.17% | 82,397 | - |
| 492 | CASI | CASI Pharmaceuticals, Inc. | 19.55M | -0.61% | 11,853 | 26.85M |
| 493 | VYNE | VYNE Therapeutics Inc. | 18.97M | 0.56% | 186,596 | 524.00K |
| 494 | TRAW | Traws Pharma, Inc. | 18.78M | 16.34% | 652,332 | 2.85M |
| 495 | CLGN | CollPlant Biotechnologies Ltd. | 18.65M | -2.67% | 9,325 | 2.48M |
| 496 | LSTA | Lisata Therapeutics, Inc. | 18.61M | -2.31% | 27,383 | 1.07M |
| 497 | OSRH | OSR Holdings, Inc. | 18.50M | -3.56% | 976,856 | -90.52K |
| 498 | KAPA | Kairos Pharma, Ltd. | 18.11M | -0.30% | 53,451 | - |
| 499 | LEXX | Lexaria Bioscience Corp. | 18.11M | -4.12% | 61,616 | 522.00K |
| 500 | ITRM | Iterum Therapeutics plc | 17.96M | -0.12% | 223,469 | 390.00K |
| 501 | KALA | KALA BIO, Inc. | 17.89M | -6.18% | 430,110 | - |
| 502 | PMN | ProMIS Neurosciences, Inc. | 17.54M | -0.40% | 9,235 | - |
| 503 | CVKD | Cadrenal Therapeutics, Inc. | 17.19M | -6.61% | 20,488 | - |
| 504 | CTXR | Citius Pharmaceuticals, Inc. | 16.93M | -4.99% | 343,081 | - |
| 505 | HOTH | Hoth Therapeutics, Inc. | 16.76M | 3.85% | 240,450 | - |
| 506 | APLT | Applied Therapeutics, Inc. | 15.70M | 2.69% | 7,021,557 | 1.00M |
| 507 | AEON | AEON Biopharma, Inc. | 15.27M | 13.16% | 420,245 | - |
| 508 | CLRB | Cellectar Biosciences, Inc. | 14.90M | -2.09% | 50,481 | - |
| 509 | COCP | Cocrystal Pharma, Inc. | 14.89M | -2.70% | 157,530 | - |
| 510 | BCDA | BioCardia, Inc. | 14.33M | -3.57% | 58,964 | 3.00K |
| 511 | SNGX | Soligenix, Inc. | 13.92M | -2.13% | 118,361 | 2.34K |
| 512 | NCNA | NuCana plc | 13.36M | -3.01% | 26,612 | - |
| 513 | MBRX | Moleculin Biotech, Inc. | 13.27M | 3.61% | 116,671 | - |
| 514 | TPST | Tempest Therapeutics, Inc. | 13.01M | -2.94% | 31,809 | - |
| 515 | CRIS | Curis, Inc. | 12.77M | -0.77% | 213,639 | 11.65M |
| 516 | AKTX | Akari Therapeutics, Plc | 12.59M | -2.00% | 49,944 | - |
| 517 | BLRX | BioLineRx Ltd. | 12.38M | 0.69% | 1,786 | 12.74M |
| 518 | SNSE | Sensei Biotherapeutics, Inc. | 12.36M | -6.13% | 44,534 | - |
| 519 | BOLT | Bolt Biotherapeutics, Inc. | 12.28M | 0.63% | 5,879 | 5.20M |
| 520 | EDSA | Edesa Biotech, Inc. | 12.08M | -0.68% | 17,680 | - |
| 521 | IMNN | Imunon, Inc. | 11.66M | -3.92% | 19,870 | - |
| 522 | GRDX | GridAI Technologies Corp. | 11.56M | -12.24% | 107,214 | - |
| 523 | GDTC | CytoMed Therapeutics Limited | 11.54M | 4.89% | 9,657 | 573.19K |
| 524 | NCEL | NewcelX Ltd. | 11.40M | 5.93% | 63,383 | - |
| 525 | PHIO | Phio Pharmaceuticals Corp. | 11.36M | -7.46% | 1,133,238 | - |
| 526 | LGVN | Longeveron Inc. | 11.34M | -3.66% | 144,878 | 1.44M |
| 527 | INAB | IN8bio, Inc. | 10.46M | -4.25% | 87,488 | - |
| 528 | APVO | Aptevo Therapeutics Inc. | 10.33M | 9.65% | 112,265 | - |
| 529 | BRTX | BioRestorative Therapies, Inc. | 9.94M | -2.61% | 13,557 | 383.40K |
| 530 | CMMB | Chemomab Therapeutics Ltd. | 9.85M | -3.61% | 73,322 | - |
| 531 | PULM | Pulmatrix, Inc. | 9.75M | 1.71% | 4,406 | 3.00K |
| 532 | ERNA | Ernexa Therapeutics Inc. | 9.65M | 1.65% | 83,695 | 1,000.00 |
| 533 | MTVA | MetaVia Inc. | 9.56M | -4.23% | 124,001 | - |
| 534 | BIVI | BioVie Inc. | 9.35M | 2.90% | 65,313 | - |
| 535 | EVGN | Evogene Ltd. | 9.11M | -2.86% | 14,957 | 8.02M |
| 536 | ALZN | Alzamend Neuro, Inc. | 9.05M | 1.28% | 43,980 | - |
| 537 | IMRN | Immuron Limited | 8.96M | -0.77% | 54,148 | 4.78M |
| 538 | PMCB | PharmaCyte Biotech, Inc. | 8.93M | -1.01% | 87,902 | - |
| 539 | QNRX | Quoin Pharmaceuticals, Ltd. | 8.57M | -0.49% | 18,133 | - |
| 540 | ABP | Abpro Holdings, Inc. | 8.38M | -11.86% | 8,279 | 183.00K |
| 541 | ICU | SeaStar Medical Holding Corporation | 8.36M | -8.30% | 85,146 | 881.00K |
| 542 | APM | Aptorum Group Limited | 8.31M | -0.97% | 9,698 | - |
| 543 | XTLB | XTL Biopharmaceuticals Ltd. | 8.10M | -5.69% | 134,785 | 968.00K |
| 544 | RNAZ | TransCode Therapeutics, Inc. | 8.06M | -1.68% | 11,765 | - |
| 545 | KPRX | Kiora Pharmaceuticals, Inc. | 8.00M | 0.93% | 9,466 | 20.00K |
| 546 | SYBX | Synlogic, Inc. | 7.96M | -39.29% | 1,518,404 | 8.00K |
| 547 | ADXN | Addex Therapeutics Ltd | 7.79M | 0.42% | 4,613 | 198.82K |
| 548 | GTBP | GT Biopharma, Inc. | 7.71M | -2.86% | 561,079 | - |
| 549 | MBIO | Mustang Bio, Inc. | 7.63M | -0.48% | 16,909 | - |
| 550 | BGMS | Bio Green Med Solution, Inc. | 7.62M | -2.81% | 28,142 | 81.00K |
| 551 | PCSA | Processa Pharmaceuticals, Inc. | 7.47M | -6.92% | 97,252 | - |
| 552 | CLDI | Calidi Biotherapeutics, Inc. | 7.44M | -1.33% | 142,200 | - |
| 553 | CELZ | Creative Medical Technology Holdings, Inc. | 6.88M | -1.50% | 72,455 | 6.00K |
| 554 | SLXN | Silexion Therapeutics Corp | 6.88M | -3.08% | 9,041 | - |
| 555 | GNPX | Genprex, Inc. | 6.72M | -3.33% | 644,546 | - |
| 556 | TCRT | Alaunos Therapeutics, Inc. | 6.67M | -2.93% | 11,562 | 6.00K |
| 557 | TOVX | Theriva Biologics, Inc. | 6.56M | -5.69% | 3,162,852 | - |
| 558 | PPBT | Purple Biotech Ltd | 6.47M | -4.42% | 141,737 | - |
| 559 | ACXP | Acurx Pharmaceuticals, Inc. | 6.22M | - | 34,674 | - |
| 560 | APRE | Aprea Therapeutics, Inc. | 6.13M | -1.44% | 18,989 | 488.24K |
| 561 | ADIL | Adial Pharmaceuticals, Inc. | 6.09M | -2.56% | 207,410 | - |
| 562 | XBIO | Xenetic Biosciences, Inc. | 5.65M | 2.03% | 45,855 | 2.86M |
| 563 | CANF | Can-Fite BioPharma Ltd. | 5.64M | -1.50% | 212,994 | 560.00K |
| 564 | ASBP | Aspire Biopharma Holdings, Inc. | 5.51M | -7.24% | 1,581,924 | 1.94K |
| 565 | REVB | Revelation Biosciences, Inc. | 5.48M | -2.53% | 18,550 | - |
| 566 | INDP | Indaptus Therapeutics, Inc. | 5.47M | -8.89% | 119,125 | - |
| 567 | VIVS | VivoSim Labs, Inc. | 5.40M | -0.96% | 6,376 | 140.00K |
| 568 | DCOY | Decoy Therapeutics Inc. | 5.21M | -10.32% | 309,802 | - |
| 569 | CYCN | Cyclerion Therapeutics, Inc. | 5.14M | -0.69% | 20,935 | 2.86M |
| 570 | GOVX | GeoVax Labs, Inc. | 4.84M | -5.69% | 119,270 | 3.35M |
| 571 | SILO | Silo Pharma, Inc. | 4.82M | -4.13% | 63,453 | 72.10K |
| 572 | PHGE | BiomX Inc. | 4.44M | 8.58% | 45,634 | - |
| 573 | CNSP | CNS Pharmaceuticals, Inc. | 4.32M | -0.99% | 20,429 | - |
| 574 | MTNB | Matinas BioPharma Holdings, Inc. | 4.31M | -2.50% | 19,236 | - |
| 575 | GLMD | Galmed Pharmaceuticals Ltd. | 4.28M | 1.28% | 40,781 | - |
| 576 | ENVB | Enveric Biosciences, Inc. | 4.10M | 2.30% | 18,006 | - |
| 577 | LYRA | Lyra Therapeutics, Inc. | 4.08M | 15.58% | 303,843 | 600.00K |
| 578 | OGEN | Oragenics, Inc. | 4.03M | 1.71% | 17,285 | - |
| 579 | XRTX | XORTX Therapeutics Inc. | 4.02M | 1.33% | 57,938 | - |
| 580 | CMND | Clearmind Medicine Inc. | 4.00M | 6.80% | 43,956 | - |
| 581 | JAGX | Jaguar Health, Inc. | 3.90M | -39.85% | 6,300,890 | 11.79M |
| 582 | HCWB | HCW Biologics Inc. | 3.77M | 1.25% | 49,622 | 422.03K |
| 583 | SPRC | SciSparc Ltd. | 3.60M | 2.80% | 136,302 | 1.31M |
| 584 | PPCB | Propanc Biopharma, Inc. | 3.50M | -16.46% | 1,095,982 | - |
| 585 | ARTL | Artelo Biosciences, Inc. | 3.43M | -0.58% | 22,695 | - |
| 586 | ONCO | Onconetix, Inc. | 3.27M | 29.23% | 148,376 | 1.22M |
| 587 | AZTR | Azitra, Inc. | 3.24M | -8.08% | 1,123,049 | 7.50K |
| 588 | CDIO | Cardio Diagnostics Holdings, Inc. | 3.18M | -3.87% | 38,557 | 15.78K |
| 589 | BBLG | Bone Biologics Corporation | 3.17M | -0.65% | 14,760 | - |
| 590 | GRI | GRI Bio, Inc. | 3.09M | -0.49% | 678,747 | - |
| 591 | ENSC | Ensysce Biosciences, Inc. | 2.96M | -3.25% | 113,294 | 4.49M |
| 592 | SCNI | Scinai Immunotherapeutics Ltd. | 2.92M | -2.77% | 14,602 | 1.15M |
| 593 | CDT | CDT Equity Inc. | 2.66M | 7.75% | 863,232 | - |
| 594 | DRMA | Dermata Therapeutics, Inc. | 2.66M | -1.74% | 1,812,930 | - |
| 595 | VRAX | Virax Biolabs Group Limited | 2.15M | -5.26% | 220,721 | 2.99K |
| 596 | ADTX | Aditxt, Inc. | 2.11M | 36.78% | 27,906,164 | 5.95K |
| 597 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.07M | -19.88% | 391,227 | 1.36M |
| 598 | BDRX | Biodexa Pharmaceuticals Plc | 1.91M | 1.79% | 152,626 | 104.90K |
| 599 | MLEC | Moolec Science SA | 1.38M | 2.18% | 71,255 | 7.83M |
| 600 | ELAB | PMGC Holdings Inc. | 632.50K | 6.92% | 240,675 | 285.95K |